BCM
Bayesian Capital Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Buy |
+26,602
| New | +$4.04M | 0.64% | 32 |
|
|
2025
Q1 | – | Sell |
-17,965
| Closed | -$3.32M | – | 669 |
|
|
2024
Q4 | $3.32M | Buy |
+17,965
| New | +$3.32M | 0.41% | 63 |
|
|
2024
Q3 | – | Sell |
-2,430
| Closed | -$502K | – | 745 |
|
|
2024
Q2 | $502K | Buy |
+2,430
| New | +$502K | 0.06% | 368 |
|
|
2024
Q1 | – | Sell |
-870
| Closed | -$206K | – | 830 |
|
|
2023
Q4 | $206K | Buy |
+870
| New | +$206K | 0.02% | 596 |
|
|
2023
Q3 | – | Sell |
-1,300
| Closed | -$273K | – | 745 |
|
|
2023
Q2 | $273K | Buy |
+1,300
| New | +$273K | 0.03% | 562 |
|
|
2023
Q1 | – | Sell |
-7,100
| Closed | -$1.55M | – | 845 |
|
|
2022
Q4 | $1.55M | Buy |
+7,100
| New | +$1.55M | 0.23% | 97 |
|
|
2020
Q3 | – | Sell |
-6,100
| Closed | -$1.06M | – | 545 |
|
|
2020
Q2 | $1.06M | Sell |
6,100
-2,700
| -31% | -$471K | 0.23% | 119 |
|
|
2020
Q1 | $1.11M | Buy |
+8,800
| New | +$1.11M | 0.24% | 104 |
|
|
2019
Q3 | – | Sell |
-2,128
| Closed | -$302K | – | 543 |
|
|
2019
Q2 | $302K | Sell |
2,128
-2,700
| -56% | -$383K | 0.06% | 356 |
|
|
2019
Q1 | $701K | Buy |
+4,828
| New | +$701K | 0.13% | 216 |
|
|
2017
Q2 | – | Sell |
-6,566
| Closed | -$591K | – | 456 |
|
|
2017
Q1 | $591K | Buy |
+6,566
| New | +$591K | 0.28% | 123 |
|